NANO Nuclear Expands Presence in Argentina by Signing Memorandum of Understanding with Dioxitek S.A., Argentina's Only Uranium Feedstock Manufacturer for Nuclear Fuel Fabrication, to Explore Opportunities in the Nuclear Fuel Supply ChainAugust 27, 2025 6:00 AM EDT | Source: NANO Nuclear Energy Inc.New York, New York--(Newsfile Corp. - August 27, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the Company"), a leading advanced nuclear energy and technology company focused on ...

Financial Data and Key Metrics Changes - Year to date loss from operations was $35.8 million, an increase of approximately $28 million from the comparable nine-month prior year period [43] - Year to date net loss totaled $32 million, up approximately $24 million from the prior year period, reflecting increases in R&D and G&A expenses [44] - Cash and cash equivalents increased to $210.2 million, an approximate $92 million increase from the end of the second fiscal quarter [45] Business Line Data and Key Metrics Changes - The company advanced its patented Cronos MMR energy system toward construction, demonstration, and licensing with the U.S. Nuclear Regulatory Commission (NRC) [20] - A strategic collaboration agreement was executed to build out the first Cronos MMR at the University of Illinois Urbana Champaign [21] - The company signed an MOU with UR America to explore strategic development across Argentina's uranium fuel supply chain [23] Market Data and Key Metrics Changes - Analysts project U.S. electricity consumption to rise at approximately 2.4% CAGR between 2022 and 2030, with data centers expected to comprise 8% of U.S. power by 2030 [12][13] - There is a growing global commitment to triple nuclear capacity by 2050, solidifying growth in nuclear energy as a secular trend for the coming decades [11] Company Strategy and Development Direction - The company is focused on a vertically integrated strategy to derisk microreactor development and enhance its competitive position [6][8] - The acquisition of Cronos MMR microreactor positions the company as a North American leader in microreactor commercialization [6] - The company aims to secure key stages of the nuclear fuel supply chain as a strategic priority [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to capitalize on macro trends driving demand for advanced nuclear solutions [9] - The company highlighted the importance of bipartisan legislative and policy support for nuclear energy, which has emerged as a strategic focus for national security and climate goals [14][15] - Management is optimistic about the future, citing a strong team and a clear vision for commercialization [17] Other Important Information - The company closed a private placement for net proceeds of $99 million, strengthening its balance sheet and expanding institutional ownership [9] - Recent personnel additions and collaborations validate the company's strong competitive position [25][27] Q&A Session Summary Question: Progress in Canada to license there - The company is focused on reengaging with the Canadian licensing process and has almost completed the legal process of taking the holding entity out of bankruptcy [51][52] Question: Commercial sales opportunities for ALIP - The company is completing the SBIR Phase three process with the DOE, which will enable it to become a default contractor for supplying ALIP technology [58] Question: Cash usage during the remainder of 2025 and into 2026 - The estimated cash burn over the next twelve months is around $40 million, primarily for hiring and operational support [68] Question: Strategy of vertical integration - The company is examining how to involve itself in upstream processes like mining, milling, and conversion to derisk the fuel supply chain [75] Question: Application for the DOE Advanced Reactor pilot program - The company did not apply for the DOE program as it would result in higher costs and no commercial benefit [80][82] Question: Supply chain for nuclear grade graphite - The company is negotiating with suppliers for components like nuclear grade graphite and reactor pressure vessels, which will need to be outsourced [87]

Financial Data and Key Metrics Changes - Centrus Energy reported revenue of $73.1 million for Q1 2025, an increase of $29.4 million compared to Q1 2024 [19][20] - The company achieved a net income of $27.2 million, a significant improvement from a net loss of $6.1 million in the same quarter last year [19][20] - Gross profit for the quarter was $32.9 million, compared to $4.3 million in Q1 2024 [19][20] - The cash balance at the end of Q1 2025 was $685.7 million, including $32.7 million of restricted cash [24] Business Line Data and Key Metrics Changes - The LEU segment generated $51.3 million in SWU revenue, an increase of $27.7 million year-over-year, driven by higher volume and average price per SWU sold [20] - The LEU cost of sales for SWU decreased from $23.1 million in Q1 2024 to $20.1 million in Q1 2025, reflecting a 48% decrease in average unit cost [20] - The Technical Solutions segment reported revenue of $21.8 million, up $1.7 million from the previous year, but gross profit decreased to $1.7 million due to delays in obtaining storage cylinders [21][22] Market Data and Key Metrics Changes - The total company backlog was $3.8 billion as of March 31, 2025, with the LEU segment backlog at approximately $2.8 billion [22] - The LEU segment backlog includes $700 million of future SWU and uranium deliveries and $2.1 billion in contingent LEU sales commitments [22] Company Strategy and Development Direction - Centrus aims to secure sufficient public and private capital to expand its enrichment capacity and restore America's uranium enrichment capability [11][19] - The company is pursuing four parallel readiness initiatives, including strengthening its balance sheet and expanding centrifuge manufacturing capacity [12][13] - Centrus emphasizes the importance of reducing dependency on foreign nations and increasing competition in the market for enriched uranium [26][28] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing uncertainty in the global trade environment but reported no impact on operations from tariffs [8][10] - The company is optimistic about the Department of Energy's plans to award $2.7 billion for fuel awards, indicating a positive momentum [31][32] - There is a clear market demand for enriched uranium, particularly for national security purposes and the upcoming advanced reactor markets [18][19] Other Important Information - Centrus is the only company currently enriching uranium with U.S.-owned technology and has a domestic supply chain [7][26] - The company has received political support for its initiatives, with bipartisan backing from local and federal officials [16][17] Q&A Session Summary Question: Update on Department of Energy activity - Management indicated that the DOE is moving quickly and plans to award $2.7 billion, with a lot of activity and momentum observed [31][32] Question: Status of Russian shipment activity - Management confirmed that the process for Russian shipments remains unchanged, with normal business operations continuing [33] Question: Licensing for HALEU production - Management explained that obtaining a HALEU license is a lengthy and costly process, taking years and requiring significant investment [36][37] Question: Timing of SWU and uranium sales - Management noted that customer reloads typically occur every 18 to 24 months, which drives revenue timing [67] Question: Impact of tariffs on customer discussions - Management stated that there have been no disruptions from tariffs, and their supply chain is fully domesticated, reducing exposure compared to competitors [57][58] Question: Dynamics of SWU cost decrease - Management clarified that the 48% decrease in SWU costs was influenced by increased volume and average costing practices [75][77] Question: Competitive landscape for HALEU production - Management highlighted that Centrus is the only facility with a CAT II license for HALEU enrichment, emphasizing their first-mover advantage [80][82]

Financial Data and Key Metrics Changes - Centrus reported revenue of $73.1 million for Q1 2025, an increase of $29.4 million compared to Q1 2024 [18] - The company achieved a net income of $27.2 million, compared to a net loss of $6.1 million in the same quarter last year [18] - Gross profit for the quarter was $32.9 million, significantly up from $4.3 million in Q1 2024 [19] - The cash balance at the end of Q1 2025 was $685.7 million, including $32.7 million of restricted cash [23] Business Line Data and Key Metrics Changes - The LEU segment generated $51.3 million in SWU revenue, an increase of $27.7 million year-over-year [19] - The LEU cost of sales for SWU decreased from $23.1 million in Q1 2024 to $20.1 million in Q1 2025, driven by a 48% decrease in the average unit cost of SWU sold [19][20] - The Technical Solutions segment reported revenue of $21.8 million, up $1.7 million from the previous year, but gross profit decreased to $1.7 million due to delays in obtaining storage cylinders [20][21] Market Data and Key Metrics Changes - The total company backlog was $3.8 billion as of March 31, 2025, with the LEU segment backlog at approximately $2.8 billion [21] - The LEU segment backlog includes $700 million of future SWU and uranium deliveries and $2.1 billion in contingent LEU sales commitments [21] Company Strategy and Development Direction - Centrus aims to secure sufficient public and private capital to expand its enrichment capacity and restore America's uranium enrichment capability [11][24] - The company is pursuing four parallel readiness initiatives, including strengthening its balance sheet and expanding centrifuge manufacturing capacity [12][13] - Centrus emphasizes the importance of reducing dependency on foreign nations and increasing competition in the nuclear energy market [24][26] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing uncertainty in the global trade environment but reported no impact on operations from tariffs [7][10] - The company is confident in its investment case as the only publicly traded enricher capable of meeting commercial and national security needs [11][24] - There is a growing market for enriched uranium, particularly for national security purposes and advanced reactor markets [17] Other Important Information - Centrus has received political support for its initiatives, with bipartisan advocacy for funding to support American jobs and technology [15][16] - The company has a strong first mover advantage in domestic centrifuge production, with all manufacturing conducted in the U.S. [25] Q&A Session Summary Question: Update on Department of Energy activity - Management reported that the DOE is moving quickly and planning to award $2.7 billion, indicating positive momentum [31] Question: Status of Russian shipment activity - There have been no changes in the process, and shipments are proceeding normally without impediments [32] Question: Licensing for HALEU production - Obtaining a HALEU license is a lengthy and costly process, taking years and requiring significant investment [36] Question: Timing of SWU and uranium sales - Management indicated that customer reloads typically occur every 18 to 24 months, which drives revenue timing [68] Question: Impact of tariffs on customer discussions - To date, there have been no impacts from tariffs, and the supply chain remains fully domesticated [57] Question: Competitive landscape for HALEU production - Centrus is currently the only facility with a CAT II license for HALEU enrichment, providing a significant competitive advantage [84]